secwatch.observer — SEC 8-K summary
======================================

Issuer:     Embecta Corp. (EMBC)
CIK:        0001872789
Form:       8-K
Filed at:   2022-08-15T23:59:59+00:00
Accession:  0001872789-22-000013
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Embecta Q3 revenue $291.1M, net income $62.4M; raises H2 FY2022 margin guidance
-------------------------------------------------------------------------------

- Revenue $291.1M (-1.3% reported, +2.0% constant currency); US +4.1%, international -7.1%.
- Net income $62.4M ($1.07 diluted EPS) vs $104.7M prior year; adjusted EBITDA margin 40.5% vs 48.7%.
- Declared $0.15/share quarterly dividend, payable Sept. 14 to holders of record Aug. 26.
- Raised H2 FY2022 adjusted gross margin guidance to mid-60%s (from low-60%s) and adjusted EBITDA margin to mid-30%s (from low-30%s); maintained revenue ~$555M.
- Developing type 2 closed-loop insulin patch pump with FDA Breakthrough Device Designation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1872789/000187278922000013/0001872789-22-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1872789/000187278922000013/embc-20220815.htm
  HTML page:      https://secwatch.observer/filing/0001872789-22-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer